Ghrelin receptor signaling: a promising therapeutic target for metabolic syndrome and cognitive dysfunction.
Ghrelin receptor signaling: a promising therapeutic target for metabolic syndrome and cognitive dysfunction.
复制标题
DOI:
10.2174/187152710793361513
复制
发表时间:
2010-11
期刊:
影响因子:
--
通讯作者:
Martin B
中科院分区:
文献类型:
--
作者:
Cong WN;Golden E;Pantaleo N;White CM;Maudsley S;Martin B
The neuroendocrine hormone ghrelin is an octanoylated 28-residue peptide that exerts numerous physiological functions. Ghrelin exerts its effects on the body mainly through a highly conserved G protein-coupled receptor known as the growth hormone secretagagogue receptor subtype 1a (GHS-R1a). Ghrelin and GSH-R1a are widely expressed in both peripheral and central tissues/organs, and ghrelin signaling plays a critical role in maintaining energy balance and neuronal health. The multiple orexigenic effects of ghrelin and its receptor have been studied in great detail, and GHS-R1a-mediated ghrelin signaling has long been a promising target for the treatment of metabolic disorders, such as obesity. In addition to its well-characterized metabolic effects, there is also mounting evidence that ghrelin-mediated GHS-R1a signaling exerts neuroprotective effects on the brain. In this review, we will summarize some of the effects of ghrelin-mediated GSH-R1a signaling on peripheral energy balance and cognitive function. We will also discuss the potential pharmacotherapeutic role of GSH-R1a-mediated ghrelin signaling for the treatment of complex neuroendocrine disorders.